✦ LIBER ✦

Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial

✍ Scribed by Habl, G; Potthoff, K; Haefner, MF; Abdollahi, A; Hassel, JC; Boller, E; Indorf, M; Debus, J

Book ID: 121628664
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 223 KB
Volume: 13
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-13-345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

583 Induction Chemotherapy with Docetaxe

583 Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study

✍ Perri, F.; Muto, P.; Schiavone, C.; Ionna, F.; Aversa, C.; Maiolino, P.; Cavalca 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

8533 POSTER First Results of an Uncontro

8533 POSTER First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab+Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck

✍ Remenar, E.; Lövey, J.; Koltai, P.; Horvath, K.; Gödeny, M.; Kasler, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Impact of nutrition support on treatment

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90-03

✍ Rachel Rabinovitch; Barbara Grant; Brian A. Berkey; David Raben; Kie Kian Ang; K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Background: The aim was to evaluate the relationship between nutrition support (ns) on host toxicity and cancer outcome in patients with locally advanced head and neck squamous cell carcinoma (hnscc) undergoing definitive radiotherapy (xrt). ## Methods: We performed a secondary analysis of rad

8502 Long term (Five-year) results of Ta

8502 Long term (Five-year) results of Tax324: A Phase III Trial of Sequential Therapy comparing TPF with PF in Patients with locally advanced squamous cell cancer of the head and neck

✍ Lorch, J.; Haddad, R.I.; Fasciano, J.; Goloubova, O.; Cullen, K.; Posner, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

1260 Multicenter parallel phase II trial

1260 Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)

✍ P. Schöffski; J.Y. Blay; J. DeGreve; E. Brain; J.P. Machiels; J.C. Soria; S. Sle 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Comparison of the efficacy and safety of

Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis : A prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer

✍ Rene-Jean Bensadoun; Jamel Daoud; Brahim El Gueddari; Laurent Bastit; Rene Gourm 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract ## BACKGROUND. Topical antifungal treatments are recommended but rarely used as first‐line therapy for oropharyngeal candidiasis (OPC) in patients with cancer. Miconazole Lauriad 50‐mg mucoadhesive buccal tablet (MBT) Loramyc reportedly delivered rapid and prolonged, effective concentr